Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Health Economics and Outcomes Research|September 5, 2022
Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with OsteoarthritisStuart Silverman, Patricia Schepman, J Bradford Rice, et al.Journal of Occupational and Environmental Medicine|June 22, 2022
All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With OsteoarthritisStuart Silverman, Sheena Thakkar, Heather Sell, et al.Journal of Opioid Management|December 5, 2017
Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patientsMihran Ara Yenikomshian, Alan G White, Michael E Carson, et al.Journal of Medical Economics|October 29, 2011
Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HClNoam Y Kirson, Alan G White, Howard G Birnbaum, et al.Ocular Immunology and Inflammation|February 23, 2019
Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United StatesThomas A Albini, J Bradford Rice, Alan G White, et al.Clinical Therapeutics|October 15, 2019
Predictors of High-cost Patients With Noninfectious Inflammatory Eye DiseasesWinnie W Nelson, J Bradford Rice, Alan G White, et al.The American Journal of Managed Care|June 4, 2013
Prescription opioid abuse: challenges and opportunities for payersNathaniel P Katz, Howard Birnbaum, Michael J Brennan, et al.Pageof 3